(Q53884158)

22 May 2018

title

Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon. (English)

1 reference

22 May 2018

author name string

Cheng Y

1

1 reference

22 May 2018

Tauschel HD

2

1 reference

22 May 2018

Nilsson A

3

1 reference

22 May 2018

Duan RD

4

1 reference

22 May 2018

publication date

1 September 1999

1 reference

22 May 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

22 May 2018

volume

34

1 reference

22 May 2018

issue

9

1 reference

22 May 2018

page(s)

915-920

1 reference

22 May 2018

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

cites work

1 reference

https://api.crossref.org/works/10.1080%2F003655299750025408

Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655299750025408

Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655299750025408

The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655299750025408

Sphingomyelin hydrolysis in the gut and clinical implications in colorectal tumorigenesis and other gastrointestinal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655299750025408

Regulation of ceramide production and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655299750025408

Magnesium-dependent sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655299750025408

10.1080/003655299750025408

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018